COMMUNIQUÉS West-GlobeNewswire
-
ALK to present at the Jefferies Global Healthcare Conference in New York
29/05/2026 -
Ipsen annonce le lancement d'une opération d’actionnariat salarié
29/05/2026 -
Ipsen announces the launch of an Employee Shareholding Plan
29/05/2026 -
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
29/05/2026 -
Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split
29/05/2026 -
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
29/05/2026 -
Seer Files ITC Complaint Against Nanomics
29/05/2026 -
PICARD MEDICAL, INC. Issues Letter to Shareholders
29/05/2026 -
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
29/05/2026 -
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
29/05/2026 -
Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking?
29/05/2026 -
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
29/05/2026 -
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
29/05/2026 -
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
29/05/2026 -
Glass House Brands Completes Previously Announced Warrant Redemption
29/05/2026 -
Dr. Kamalesh Sets New Benchmarks for Urological Surgery in the UAE: Minimally Invasive, Maximum Results!
29/05/2026 -
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
29/05/2026 -
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA
29/05/2026 -
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
29/05/2026
Pages